PRS-CS targets type 2 diabetes
Evidence from:
primary |
all sources
Evidence (1 sources)
Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations.
(2022)
PMID:35765100
cited
cross-ancestry genetic architecture of T2D is consistent with the modeling assumptions in PRS‑CSx
confidence: 0.80